Kimberley-based tech start-up company AutomatIQ Technologies Inc., an up and coming disruptive player in advanced computing and software development, April 17 announced the soft launch of ​Sixth Sense​, a chest radiography AI (artificial intelligence) tool that significantly improves the accuracy and timeliness of diagnosing lung abnormalities.

The company’s first healthcare product is seeking expedited Health Canada approval.

“We have been working on this artificial intelligence product for just over two years and could not be more pleased with our progress,” said Kris Cote, Chief Executive Officer of AutomatIQ Technologies Inc.

Sixth Sense can be deployed on classical processors in the cloud or on-premise, helping clinicians better identify patients with respiratory complications including SARS, pneumonia, tuberculosis, and other abnormalities. In evaluating publicly available data of COVID-19 pneumonia, Sixth Sense accurately identified 100% of cases with pulmonary abnormalities with an average of 99.8% accuracy. Just importantly, it detects healthy patients – which can help get the economy moving, when the time is right.

AutomatIQ is a technology start-up in advanced computing and software development. The company is based in the East Kootenay and headquartered in Kimberley and is made up of a network of physicians, biomedical experts , mathematicians, computer scientists, physicists, chemists, software developers, and other quantum computing specialists.

The company develops novel solutions to computational problems along the full stack of quantum computing, from autonomous vehicles to commercial application development.

Submitted

Article Share